Amneal Pharmaceuticals, Inc. (AMRX) Cash Flow Statement
Amneal Pharmaceuticals, Inc. (AMRX) generated $200.8M of operating cash flow over the twelve months to 2026-06-30, spent $117.7M on capital expenditure and had free cash flow of $83.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
AMRXAmneal Pharmaceuticals, Inc.Follow AMRX — free
—
Price chart with a free account
- Market cap
- 6.5B
- P/E TTM
- 41.6
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 0.25 | 0.00 | 0.38 | 0.24 | 0.07 | 0.35 | 0.30 | 0.34 | 0.20 | |
| Capital expenditure | 0.08 | 0.05 | 0.06 | 0.05 | 0.05 | 0.05 | 0.06 | 0.10 | -0.12 | |
| Free cash flow | 0.17 | -0.05 | 0.32 | 0.19 | 0.02 | 0.30 | 0.23 | 0.24 | 0.08 | |
| Dividends paid | 0.18 | 0.00 | 0.00 | — | — | — | — | — | — | |
| Stock-based compensation | 0.17 | 0.02 | 0.02 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | — |
USD billions · SEC XBRL
Amneal Pharmaceuticals, Inc. — questions
- What is Amneal Pharmaceuticals, Inc.'s operating cash flow?
- $200.8M over the twelve months to 2026-06-30.
- How much does Amneal Pharmaceuticals, Inc. spend on capital expenditure?
- $117.7M over the twelve months to 2026-06-30.
- What is Amneal Pharmaceuticals, Inc.'s free cash flow?
- $83.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Amneal Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.